Select language:  
1800 620 420
Close menu

Optimal Care Pathways for AL-amyloidosis

An illustration of two people embracing, with the text Optimal Care Pathways for patients and loved ones over the top.

AL-amyloidosis was previously known as “primary systemic amyloidosis”. In AL amyloidosis, the amyloid forming protein is derived from the light chain component of a protein in the blood called monoclonal immunoglobulin. These light chains are produced by abnormal cells (called plasma or B cells) which are usually in the bone marrow. The underlying bone marrow disorder is known by many different names (MGUS – monoclonal gammopathy of undetermined significance, plasma cell dyscrasia, paraprotein disorder etc) and in most cases is very subtle.

A disease-specific Guide to Best Cancer Care has been developed for the following disease. The guide helps people with cancer to understand the optimal cancer care they should be provided and support people to understand what might happen at each step of their cancer experience and consider what questions to ask.



Relevant information that may be of interest for AL-amyloidosis patients

AL-amyloidosis information

Support groups

Join one of our regular support groups


Listen to one of our informative podcasts


Watch our recorded webinars